Wednesday, April 25, 2012

Larger-than-life Painted Cats will again be raising funds for Cat Care Society shelter cats

The 2012 'Tails of the Painted Cats,' the Cat Care Society's lineup of 18 one-of-a-kind, larger-than-life artwork cats - created by accomplished area artists - will debut during the month of May at the Lakewood Arts Council Co-op Gallery, 85 South Union Blvd., Suite C. A reception, open to the general public at the LAC Gallery, is Thursday, May 3, 6:30 - 8:30 p.m. The announcement is made by CCS President Diane Stoner, who says, "Our wonderful Painted Cats will again be raising funds for Cat Care Society's shelter cats and community outreach programs. Last year, we raised more than our $30,000 goal, and hope to do the same with our project this year." (that's Little Roar by Jane McFadden Dorsey pictured - http://www.catcaresociety.org/pc_little_roar.html)

Some of the Painted Cats are standing, and some are sitting, but they are all unique, original decorator pieces. You can visit the Online Gallery at http://www.catcaresociety.org/paintedcatsgallery.html - the larger (about 28" tall) Painted Cats each have an opening bid of $300 and the smaller Painted Cats open at $150. Advanced online bidding is available at http://BidOnACat.blogspot.com through Wednesday, July 25, 2012, at noon (MDT). Advanced bids can also be placed by calling Suellen Scott, CCS director of development, at 303-239-9680, ext. 19.

After the LAC Gallery during May, the second tour stop will be the Santa Fe Arts District during June, where the Painted Cats will be separated at galleries throughout the area in time for the First Friday Art Walk. Next, they will make an appearance at the Aar River Gallery in Westminster on June 29th for a Cat Care Society wine tasting. From Westminster, the Painted Cats head to the Tennyson Street Cultural District and will be placed in various businesses and galleries during July.

On July 28th, the Painted Cats will be auctioned at Cat Care Society's Gala Dinner Auction at Lakewood Country Club. The emcee is Ed Greene, CBS4 weather and news anchor. The auctioneers are Warren and Terri Smith of Two for the Show Auctions. Individual tickets for the Gala are $75.00 each ($65.00 prior to June 1).  New this year is an individual patron ticket to a private VIP Meet & Greet prior to the dinner on July 28 where Ed Greene will sign the 2013 'Weather Cat' painted cat -- $100.00 each ($90.00 prior to June 1). Details regarding sponsorships, table upgrades and proxy bidding are also available by calling Suellen Scott, CCS director of development, at 303-239-9680, ext. 19.

Link to the PR Web newswire

Link ot the PitchEngine Social Media Release

Link to the Lakewood Pet Examiner's Recent Article

Tuesday, April 24, 2012

Colorado BioScience Association Seeks Region’s Top Start-up Companies for Venture Showcase Competition at BioWest 2012

Colorado BioScience Association (CBSA) is now accepting applications from emerging bioscience companies for the Venture Showcase Competition at BioWest 2012, being held September 11th at the Marriott City Center, Denver. The announcement is made by CBSA President & CEO Holli Riebel, who says, "Six finalists will be selected from the applicants and the winner will receive a $7,500 cash prize at the competition."

"The Venture Showcase creates a huge amount of excitement at the BioWest Conference and gives our emerging bioscience companies an opportunity to present their technologies on a large scale. Our sponsors this year include Dorsey & Whitney LLP, EKS&H - Ehrhardt Keefe Steiner & Hottman PC, and the Metro Denver Economic Development Corporation. We're appreciative of their support of this important, and popular, competition," Riebel explains.

The six selected finalists will receive expert coaching to fine tune their presentations leading up to the conference.  Each start-up company will have 15 minutes to pitch their technologies and business plans to a panel of bioscience experts and venture capitalists in-front of a live audience at the BioWest Conference & Expo. The cash prize will be given to the outstanding presenting company live at the Conference closing reception.

Link to the Business Wire Release

Link to the PitchEngine Social Media Release

Wednesday, April 18, 2012

Denver Post: 'Fitzsimons Redevelopment Authority appoints Steve VanNurden as CEO'

Quoting from denverpost.com - posted April 17, 2012:

"The Fitzsimons Redevelopment Authority today said it has named Steve VanNurden as its new president and chief executive officer.

VanNurden will start in the position in late May.

VanNurden is currently chairman of Mayo Clinic Ventures, the invention arm for Mayo Clinic. The division is responsible for patenting and commercializing Mayo's discoveries, inventions and other intellectual property."

Link to denverpost.com

BCBR: 'Biotech building draws fresh funding'

Quoting from yesterday's article in the Boulder County Business Report:

"Biofrontiers Institute hopes to receive $3 million per year in federal funding for its Interdisciplinary and Quantitative, or IQ Biology program, which will bring 10 doctoral students together per year who have experience in computational math, differential equations, biology, modeling, simulations, and the like, to take classes and do specialized research, Cech said.

Cech, Marvin Caruthers, a founder of the biotechnology company Amgen Inc., a building donor and a CU researcher, and other leaders in the regional biotechnology industry gathered at the building for a Bioscience Roundtable Tuesday to talk about the challenges of finding funding for new companies and the opportunities to draw venture capitalists to Boulder. The roundtable was organized by the Boulder County Business Report and sponsored by law firm Berg Hill Greenleaf & Ruscitti and the accounting firm EKS&H PC...

...Also attending the roundtable were Bill Marshall, president and chief executive of miRagen Therapeutics Inc. in Boulder, Pete Neidecker, executive vice president of Mountainside Medical Colorado in Boulder, Holli Riebel, president and chief executive of the Colorado BioScience Association in Denver, David Snitman, co-founder of Array Biopharma Inc. in Boulder and David Traylor, managing director of Headwaters MB in Denver."

Link to the Boulder County Business Report

Monday, April 16, 2012

'The mother of inventions...Denise Brown stepping down from unique Colorado projects and an industry she helped create'

Quoting from the April 10th article on Denise Brown's career growing Colorado's Bioscience Industry by Brandon Johannson:

"When she retires next month, Brown will cap a career during which she has been as involved in Colorado and Aurora’s booming bioscience industry as just about anyone.

After working in the state legislature and the governor’s office, Brown spent 17 years at CU before launching the Colorado BioScience Association a decade ago."

Link to the Aurora Sentinel

Monday, April 09, 2012

DBJ: 'Clinical trials abundant; more sought for Colorado'

Quoting from the April 6th article by Ed Sealover:

"Colorado was home to more than 3,000 clinical drug trials in the past 12 years — a little-known but increasingly important factor in the state’s health care economy.

A new study out by the Pharmaceutical Research and Manufacturers of America (PhRMA) doesn’t detail the economic impact of such trials. Nevertheless, state officials estimate that impact could be in the billions of dollars, and they’re promoting Colorado as a place for biotech and medical research expansion...

...It also can help to develop Colorado’s growing biopharmaceutical industry, which includes about 300 companies employing more than 5,410 people, according to the Colorado Bioscience Association. A 2008 study by Archstone Consulting of Miami found that biopharmaceutical companies invested $379.9 million in research and development in Colorado that year."

Link to the DBJ

GEN: 'Colorado BioScience Association Appoints Four Industry Leaders to Board of Directors'

Quoting from the April 5th GEN (via Biowire):

"The Colorado BioScience Association (CBSA) appointed four new board members at its 2012 Annual All-Member Meeting held at the Westin Westminster, Westminster, CO, yesterday. The announcement is made jointly by Steve Orndorff, Ph.D., Chairperson of the Board of Directors and Holli Riebel, CBSA President & CEO of CBSA.

Newly appointed CBSA board members include:

James Chomas, Ph.D., Founder & CEO, Surefire Medical - Westminster -www.surefiremedical.com

Scott Deeter, President & CEO, Ventria Bioscience - Fort Collins - www.ventria.com

Brent Fassett, Partner, Cooley LLP - Broomfield - www.cooley.com

Kerry Ingalls
,Vice President of Colorado Operations, Amgen - Boulder/Longmont - www.amgen.com

Riebel says: 'CBSA’s board is a prestigious group of industry leaders comprised of representatives of biotechnology, medical device, diagnostic, pharmaceutical, health care providers, research institutions and those businesses that provide critical services and products to bioscience companies. Board members commit to a three-year term to support CBSA’s mission to support the regional bioscience community through advocacy, resources and advancement of opportunities for collaboration. CBSA board members work in partnership with staff to support the drive and determination of over 600 Colorado bioscience companies that work to improve lives locally and around the world.'"

Link to GEN

NCBR: 'Colorado BioScience Association appoints Deeter to board'

Quoting from the April 5th Northern Colorado Business Report:

"The Colorado BioScience Association has named four new board members, including Scott Deeter, president and CEO of Ventria Bioscience in Fort Collins.

James Chomas, founder and CEO of Surefire Medical in Westminster, Brent Fassett, partner at Cooley LLP in Broomfield, and Kerry Ingalls, vice president of Amgen's Colorado operations, also were appointed. Board members commit to a three-year term to back the regional bioscience community."

Link to the NCBR

CRJ: 'Colorado bioscience cluster alive and well'

Quoting from the April 4th article in the Colorado Real Estate Journal:

"The biosciences industry is alive and well in the Denver metro area, and that bodes well for future demand for manufacturing and lab/research-and-development space.

'Bioscience is one of the few industry sectors that have grown during the bad economy and actually exceeded the national average,' said Holli Riebel, president and CEO of the Colorado BioScience Association.'"

Link to the article

'Made in Colorado: Pharmaceuticals and Medical Technology'

More than a dozen of the Colorado BioScience Association member companies are featured in the current ColoradoBiz Magazine 'Made In Colorado' feature by Debra Melani.

Link to read

Friday, April 06, 2012

The Tails of the Painted Cats Video Art Gallery is OPEN!

Cat Care Society Tails of the Painted Cats - 2012.

Check out our Video Art Gallery:

http://youtu.be/F_MNKEMJGKE

One-of-a-kind "painted cats" by well-known Denver artists will once again raise funds for the Cat Care Society's shelter cats and community outreach programs. The cats will be unveiled at the Lakewood Arts Council Co-op Gallery in May (reception May 3) and will reside there through the month. In June the cats will be at various galleries in the Santa Fe Arts District for the First Friday Art Walk June 1. On June 29, the cats arrive at the Aar River Gallery in Westminster for the CCS wine tasting (featuring our CCS Cat Care Vineyards wines!). Finally, the cats head to various businesses and galleries in the Tennyson Street Cultural District, before heading to Lakewood Country Club for the July 28th Gala Dinner Auction emceed by CBS4's Ed Greene.

Visit the Tails of the Painted Cats Facebook page: http://www.facebook.com/TailsofthePaintedCats

Thursday, April 05, 2012

Colorado BioScience Association Appoints Four Industry Leaders to Board of Directors

The Colorado BioScience Association (CBSA) appointed four new board members at its 2012 Annual All-Member Meeting held at the Westin Westminster, Westminster, CO, yesterday. The announcement is made jointly by Steve Orndorff, Ph.D., Chairperson of the Board of Directors and Holli Riebel, CBSA President & CEO of CBSA.

Newly appointed CBSA board members include:

* James Chomas, Ph.D., Founder & CEO, Surefire Medical - Westminster - www.surefiremedical.com
* Scott Deeter, President & CEO, Ventria Bioscience - Fort Collins - www.ventria.com
* Brent Fassett, Partner, Cooley LLP - Broomfield - www.cooley.com
* Kerry Ingalls, Vice President of Colorado Operations, Amgen - Boulder/Longmont - www.amgen.com

Riebel says: "CBSA’s board is a prestigious group of industry leaders comprised of representatives of biotechnology, medical device, diagnostic, pharmaceutical, health care providers, research institutions and those businesses that provide critical services and products to bioscience companies. Board members commit to a three-year term to support CBSA’s mission to support the regional bioscience community through advocacy, resources and advancement of opportunities for collaboration. CBSA board members work in partnership with staff to support the drive and determination of over 600 Colorado bioscience companies that work to improve lives locally and around the world."

“On behalf of the Board of Directors, I would like to thank the retiring eleven directors for their service and welcome the four new appointees,” Orndorff stated. Special recognition was given to Norwood Robb for serving on the board for ten years. The Executive Officers , in addition to Orndorff, is now instated as Derek Cole, Board Vice Chair, Vice President, Investor Relations & Corporate Communications, ARCA Biopharma; Jim Wilson, Board Treasurer, Senior Audit Manager, Ernst & Young; and John Dunning, Board Secretary, President & CEO, Clarimedix Inc.

Link to the Business Wire Newswire

Sunday, April 01, 2012

BioBeers Denver: April 25th at the new Cedar Creek Pub

Mark your calendars: April 25, 6:30 p.m.

The new home for BioBeers Denver is only a chip shot from the Fitzsimons-based Bioscience Park Center building; the new Cedar Creek Pub promises to provide an ideal backdrop for BioBeers networking, knowledge exchange and fun. Note: the 2100 North Ursula St. address is off of Montview Blvd. in the 21 Fitzsimons round-about.

No admission - "Buy Your Own Beer" - for casual networking with your Denver med device, biopharma and diagnostics colleagues.

Link to RSVP at the BioBeers Meetup Site